SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
93
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of HMS Holdings Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2017 – HMSY

NEW YORK, March 20, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of HMS Holdings Corp. ("HMS Holdings") (NASDAQ: HMSY ) between May 10, 2016 and March 2, 2017 . You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:

http://www.zlk.com/pslra-sa/hms-holdings-corp

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) HMS lacked effective internal control over financial reporting; and (2) as a result, HMS’s financial statements were materially false and misleading at all relevant times.

On March 2, 2017, the Company announced it would delay filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2016. The Company stated it needed additional time in order to "complete documentation related to the Company's previously disclosed review of its CMS reserves and related internal controls over financial reporting. In this regard, the Company's auditor has informed the Company that it has identified what it believes is a material weakness in the Company's internal controls over financial reporting related to the CMS reserves."

If you suffered a loss in HMS Holdings you have until May 2, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fort Riley and Fort Wainwright Get Wi-Fi Boost

Updated Category News Views 11

Reliable Connectivity for Soldiers: A Strategic Move Wi-Fi probably wouldn't be on top of the list in a battlefield strategy session, but give it a thought—it’s the digital lifeline for our troops off-duty. That’s what’s cooking with the U.S. Army’s big move to amp up reliable Wi-Fi at Fort Riley and Fort Wainwright, thanks to Boldyn Networks and their BaseNet...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 240

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 83

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 671

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Wendy C. Wilson Earns Inner Circle Pinnacle Honor

Updated Category News Views 20

Leadership Recognized: Wendy C. Wilson's Impact Some folks know their way around the trenches of corporate battle, and Wendy C. Wilson is one of them. Known for her grit and savvy, she now takes a coveted spot in The Inner Circle of Excellence as a Pinnacle Professional Member. This title isn't just for show—it's a hat tip to her powerhouse contributions as a speaker on...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 23

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 99

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Alscan Clinches Three PSA Awards, Sets Industry Standard

Updated Category News Views 46

Alscan's Triple Trophy Triumph with PSA Network in 2026 Talk about setting the bar high! Alscan snagged not one, not two, but three prestigious awards from the PSA Network—quite a haul for any outfit looking to make waves in the security systems game. The recognition showcases their prowess in custom security solutions, serving businesses and industries with vigilance...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 194

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Upgrades for Top Stocks: Analysts Favor Henry Schein

Updated Category News Views 143

Top Analyst Upgrades for Leading Stocks In the dynamic world of investing, analyst ratings can significantly influence stock performance. Recently, top Wall Street analysts have revised their outlooks on several prominent companies, providing fresh insights for investors. Here’s a look at the latest upgrades and what they could mean for these stocks. Okta Receives a...

Continue Reading
Multiple Sclerosis Diagnosis and Treatment Market Insights

Updated Category News Views 112

Overview of the Multiple Sclerosis Diagnosis and Treatment Market The global market for multiple sclerosis (MS) diagnosis and treatment is experiencing steady growth, currently valued at around USD 22.14 billion. Forecasts suggest that this figure could rise to USD 30.28 billion by 2032. This growth is largely driven by the increasing number of MS cases and advancements...

Continue Reading
Checkbook Teams Up with J.P. Morgan to Transform Payments

Updated Category News Views 200

Checkbook Partners with J.P. Morgan Payments Network San Mateo, CA - Checkbook, an innovator in digital payments, announced its membership in the J.P. Morgan Payments Partner Network. This collaboration aims to transform the realm of digital check payments, making it easier for corporate clients of J.P. Morgan Payments to send digital checks directly from their bank...

Continue Reading
Lemonade Exceeds Expectations: Earnings and Revenue Insights

Updated Category News Views 154

Lemonade's Impressive Earnings Performance Lemonade (NYSE: LMND) recently delivered its third quarter earnings, posting an EPS of $-0.95, which is $0.07 better than analysts' expectations of $-1.02. This performance highlights the company's resilience and ability to navigate market challenges effectively. Despite operating in a competitive landscape, Lemonade's innovative...

Continue Reading
Understanding the Rise in GigaCloud Tech's Short Interest

Updated Category News Views 102

Examining the Increase in GigaCloud Tech's Short Interest GigaCloud Tech has seen a significant rise in its short percent of float, increasing by 3.8% since the last report. Currently, the company indicates that 5.85 million shares have been sold short, which accounts for 31.11% of all regular shares available for trading. This implies that traders may need an average of...

Continue Reading